Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alluzience vs Powder BoNT-A for Glabellar Lines
NCT05277337Phase 4Completed
- Sponsor
- Galderma
- Start
- Feb 2022
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of alluzience in glabellar lines, sponsored by Galderma. Started Feb 2022; status: completed.
02
Drugs
alluzience
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT05277337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05277337.